Bristol-Myers Squibb Guides FY26 Above Estimates - Update

While reporting financial results for the fourth quarter on Thursday, Bristol-Myers Squibb Co. (BMY) initiated its adjusted earnings and revenue growth guidance for the full-year 2026, above analysts' estimates.For fiscal 2026, the company now projects adjusted earnings in a range of about $6.05 to $6.35 per share on worldwide total revenues between about $46.0 billion and $47.5 billion.On average, 25 analysts polled expect the company to report earnings of $6.04 per share on a revenues decline of 7.85 per ...